August 28, 2015 - 3: Initial statement of beneficial ownership of securities

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Micallef Jacob Vincent

2. Date of Event Requiring Statement (Month/Day/Year)
08/18/2015

3. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [VNRX]

(Last)

(First)

(Middle)

1 SCOTTS ROAD, #24-05 SHAW CENTRE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chief Scientific Officer

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

SINGAPORE, U0 228208

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common	86,166	D
Common	14,290	I ⁽¹⁾	Borlaug Limited

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant (Right to Buy)	05/11/2012	05/10/2016	Common Stock	5,000	$ 2.6	I ⁽³⁾	Borlaug Limited
Stock Option (Right to Buy)	05/25/2012	05/25/2016	Common Stock	20,000	$ 3	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	11/25/2012	11/25/2016	Common Stock	20,000	$ 3	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	05/25/2013	05/25/2017	Common Stock	20,000	$ 4	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	11/25/2013	11/25/2017	Common Stock	20,000	$ 4	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	05/25/2014	05/25/2018	Common Stock	20,000	$ 5	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	11/25/2014	11/25/2018	Common Stock	20,000	$ 5	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	12/13/2012	12/13/2015	Common Stock	50,000	$ 3.01	I ⁽²⁾	Borlaug Limited
Warrant (Right to Buy)	11/25/2013	11/25/2018	Common Stock	4,290	$ 2.4	I ⁽³⁾	Borlaug Limited
Warrant (Right to Buy)	02/26/2014	02/26/2019	Common Stock	10,000	$ 2.2	D
Stock Option (Right to Buy)	02/18/2015	02/18/2019	Common Stock	65,000	$ 2.5	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	02/18/2016	02/18/2020	Common Stock	65,000	$ 3	I ⁽²⁾	Borlaug Limited
Stock Option (Right to Buy)	01/23/2016	01/23/2020	Common Stock	55,000	$ 4	I ⁽²⁾	Borlaug Limited

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Micallef Jacob Vincent 1 SCOTTS ROAD #24-05 SHAW CENTRE SINGAPORE, U0 228208			Chief Scientific Officer

Signatures

/s/ Jacob Vincent Micallef		08/28/2015
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These shares of Common Stock are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares. However, Dr. Micallef disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(2)	These options to purchase Common Stock were granted pursuant to the Issuer's 2011 Equity Incentive Plan dated November 17, 2011, and are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common shares issuable to Borlaug Limited upon the exercise of these options. However, Dr. Micallef disclaims beneficial ownership of these Options and Warrants except to the extent of his pecuniary interest therein.
(3)	These Common Stock Warrants are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common shares issuable to Borlaug Limited upon the conversion of these Warrants. However, Dr. Micallef disclaims beneficial ownership of these Options and Warrants except to the extent of his pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.